Holen Sie sich die Stockscreener-App
1.16
0.85%
-0.01
Vorhandelsmarkt:
1.15
-0.01
-0.86%
Schlusskurs vom Vortag:
$1.17
Offen:
$1.15
24-Stunden-Volumen:
365.35K
Relative Volume:
0.06
Marktkapitalisierung:
$25.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.28M
KGV:
-0.0834
EPS:
-13.91
Netto-Cashflow:
$-13.75M
1W Leistung:
-0.85%
1M Leistung:
+58.67%
6M Leistung:
+31.64%
1J Leistung:
-60.54%
1-Tages-Spanne:
$1.12
$1.19
1-Wochen-Bereich:
$1.09
$1.23
52-Wochen-Spanne:
$0.281
$3.85
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Firmenname
Pasithea Therapeutics Corp
Sektor
Branche
Telefon
(702) 514-4174
Adresse
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Vergleichen Sie KTTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
1.16 | 26.21M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pasithea Therapeutics Corp Aktie (KTTA) Neueste Nachrichten
What is HC Wainwright’s Forecast for KTTA FY2025 Earnings? - Defense World
HC Wainwright Begins Coverage on Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
There is no way Pasithea Therapeutics Corp (KTTA) can keep these numbers up - Setenews
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
HC Wainwright & Co. Initiates Coverage of Pasithea Therapeutics (KTTA) with Buy Recommendation - Nasdaq
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com
HC Wainwright Initiates Coverage on Pasithea Therapeutics With Buy Rating, $3 Price Target - marketscreener.com
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Pasithea Therapeutics Corp. stock attractive for hedge funds2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Small Cap Stocks To ConsiderNovember 30th - MarketBeat
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from commodity prices2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Insiders Buying Pasithea Therapeutics Might Wish They Invested More, Stock Gains 10% - Yahoo Finance
Pasithea Therapeutics Reaches US$104m Market Cap Benefiting Insider Stock Buying - simplywall.st
Lawrence Steinman Bought 201% More Shares In Pasithea Therapeutics - Yahoo Finance
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Top Biotech Stocks To Watch TodayNovember 29th - MarketBeat
Small Cap Stocks To Follow NowNovember 29th - MarketBeat
Best Small Cap Stocks To Keep An Eye OnNovember 28th - MarketBeat
Pasithea Therapeutics Completes $60M Public Offering - TipRanks
Promising Penny Stocks To ConsiderNovember 30th - MarketBeat
Pasithea Therapeutics announces closing of $60 million public offering of common stock - marketscreener.com
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock - GlobeNewswire
Best Penny Stocks To Watch TodayNovember 29th - MarketBeat
Small Cap Stocks To Consider – November 30th - Defense World
Published on: 2025-12-02 03:15:38 - Newser
Biotech Stocks To Watch Today – November 30th - Defense World
Pasithea Therapeutics (KTTA) Stock Analysis Report | Financials & Insights - Benzinga
Insider Buying Spree at Pasithea Therapeutics: Top Executives Invest Big! - TipRanks
Biotech Stocks To Watch TodayNovember 30th - MarketBeat
Pasithea Therapeutics Stock (KTTA) Opinions on PAS-004 Drug Updates - Quiver Quantitative
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock By Investing.com - Investing.com Canada
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares By Investing.com - Investing.com Canada
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 By Investing.com - Investing.com Canada
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock - Investing.com India
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares - Investing.com
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 - Investing.com
Pasithea Therapeutics Executives and Directors Make Significant Stock Purchases - TradingView
Dir Dumesnil Buys 33,333 ($25K) Of Pasithea Therapeutics Corp [KTTA] - TradingView
Ready to Jump After Recent Trade: Pasithea Therapeutics Corp (KTTA) - Setenews
Pasithea Prices $60 Mln Offering To Advance PAS-004 And Broader Pipeline - Nasdaq
Top Biotech Stocks To Watch Today – November 29th - Defense World
Pasithea Therapeutics Reports Positive Phase 1 Data for PAS-004 - MSN
Penny Stocks To Follow NowNovember 28th - MarketBeat
Penny Stocks To Follow TodayNovember 27th - MarketBeat
Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):